Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 5/20 | 0.75 |
| ▸ | ELANE | P08246 | 4/20 | 0.75 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.75 |
| ▸ | MEN1 | O00255 | 4/20 | 0.75 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.75 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.75 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.75 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.75 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.75 |
| ▸ | TSHR | P16473 | 2/20 | 0.75 |
| ▸ | BRCA1 | P38398 | 2/20 | 0.75 |
| ▸ | RECQL | P46063 | 2/20 | 0.75 |
| ▸ | USP2 | O75604 | 1/20 | 0.75 |
| ▸ | BCL2 | P10415 | 3/20 | 0.68 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.68 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.66 |
| ▸ | MAOA | P21397 | 3/20 | 0.66 |
| ▸ | CYP1A1 | P04798 | 2/20 | 0.66 |
| ▸ | MAOB | P27338 | 2/20 | 0.66 |
| ▸ | CYP1B1 | Q16678 | 2/20 | 0.66 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Pachybasin SCHEMBL31536859 | 1.00 | MAPT (0.75) | MAPTELANEALDH1A1MEN1KMT2A | |
| SCHEMBL11077084 | 0.93 | MAPT (0.65) | MAPTELANEALDH1A1MEN1KMT2A | |
| Chrysophanol SCHEMBL9879838 | 0.90 | ALDH1A1 (0.94) | MAPTELANEALDH1A1MEN1KMT2A | |
| SCHEMBL19461856 | 0.87 | ALDH1A1 (0.90) | MAPTELANEALDH1A1MEN1KMT2A | |
| SCHEMBL12304029 | 0.86 | ELANE (0.85) | MAPTELANEALDH1A1MEN1KMT2A | |
| Chrysophanol SCHEMBL8674524 | 0.86 | ALDH1A1 (1.00) | MAPTELANEALDH1A1MEN1KMT2A | |
| Chrysophanol SCHEMBL29364442 | 0.86 | ALDH1A1 (1.00) | MAPTELANEALDH1A1MEN1KMT2A | |
| Chrysophanol SCHEMBL308131 | 0.86 | ALDH1A1 (1.00) | MAPTELANEALDH1A1MEN1KMT2A | |
| Chrysophanol SCHEMBL30457995 | 0.86 | ALDH1A1 (1.00) | MAPTELANEALDH1A1MEN1KMT2A | |
| Chrysophanol SCHEMBL29730935 | 0.86 | ALDH1A1 (1.00) | MAPTELANEALDH1A1MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117683195-A | Anthraquinone modified polyurethane and preparation method and application thereof | 厦门理工学院 | 2024-03-12 | — | — | CN | claimed |
| EP-3943085-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2022-01-26 | — | — | EP | claimed |
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH ZURICH (CH) | 2021-06-24 | — | — | US | claimed |
| EP-3801507-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2021-04-14 | — | — | EP | claimed |
| US-20180146683-A1 | NEW PRODUCT | ALPHA BIOPESTICIDES LIMITED (GB) | 2018-05-31 | — | — | US | claimed |
| CN-107846904-A | New product | 阿尔法生物农药有限公司 | 2018-03-27 | — | — | CN | claimed |
| CN-105778404-A | Flame retardant insulation foam material and preparation method thereof | 苏州甫众塑胶有限公司 | 2016-07-20 | — | — | CN | claimed |
| CN-117683195-A | Anthraquinone modified polyurethane and preparation method and application thereof | 厦门理工学院 | 2024-03-12 | — | — | CN | disclosed |
| WO-2023199238-A1 | NOVEL COMPOUNDS TO TREAT CYTOKINE RELATED DISORDERS | ZYDUS LIFESCIENCES LIMITED (IN) | 2023-10-19 | — | — | WO | disclosed |
| WO-2023199238-A1 | NOVEL COMPOUNDS TO TREAT CYTOKINE RELATED DISORDERS | ZYDUS LIFESCIENCES LIMITED (IN) | 2023-10-19 | — | — | WO | disclosed |
| CN-107846904-B | New product | 阿尔法生物农药有限公司 | 2022-02-08 | — | — | CN | disclosed |
| EP-3943085-A2 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH Zurich (CH) | 2022-01-26 | — | — | EP | disclosed |
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | ETH ZURICH (CH) | 2021-06-24 | — | — | US | disclosed |
| WO-2016189329-A1 | NEW PRODUCT | ALPHA BIOPESTICIDES LIMITED (GB) | 2016-12-01 | — | — | WO | disclosed |
| CN-105778404-A | Flame retardant insulation foam material and preparation method thereof | 苏州甫众塑胶有限公司 | 2016-07-20 | — | — | CN | disclosed |
| CN-1106375-C | Method for preparing substd. anthraguinone and application to preparation of rheins | GIREX (FR) | 2003-04-23 | — | — | CN | disclosed |
| EP-0909268-B1 | METHOD FOR PREPARING SUBSTITUTED ANTHRAQUINONE AND APPLICATION TO THE PREPARATION OF RHEINS | GIREX (FR) | 2002-06-05 | — | — | EP | disclosed |
| EP-0801639-B1 | METHOD FOR PREPARING SUBSTITUTED ANTHRAQUINONES AND USE THEREOF FOR PREPARING RHEINS | GIREX (FR) | 2002-01-02 | — | — | EP | disclosed |
| US-6057461-A | Method for preparing substituted anthraquinone and application to the preparation of rheins | GIREX (FR) | 2000-05-02 | — | — | US | disclosed |
| CN-1216035-A | METHOD FOR PREPARING SUBSTD. ANTHRAGUINONE AND APPLICATION TO PREPARATION OF RHEINS | GIREX (FR) | 1999-05-05 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180146683-A1 | NEW PRODUCT | CYP51A1, ERG28, FASN | MAPT 3981/4885ELANE 4160/4885ALDH1A1 1756/4885 |
| US-20210186947-A1 | TOMM6-INTERACTING EXTRACTS AND COMPOUNDS FOR USE IN THE TREATMENT AND PROPHYLAXIS OF NERVOUS SYSTEM DISEASES, ATHEROSCLEROSIS, HEPATITIS B INFECTION AND HUMAN PAPILLOMA VIRUS (HPV) INFECTION | TOMM70, TOMM34, TIMM50 | MAPT 2071/4885ELANE 4808/4885ALDH1A1 3685/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.